Key facts
- Notable investors include Thematic Technology Transfer.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Morphly
- ·The full record, as it builds
Funding rounds
No funding rounds for Morphly are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Morphly
Developer of an AI-assisted platform designed to empower clinicians with custom medical device design. The company automates complex, lengthy design processes such as development of mandibular reconstruction devices while keeping clinicians central to the design process, enabling clinicians to explore and select personalized implant designs and significantly reducing delays, making tailored medical solutions faster and more accessible.
- Sector
- Information Technology
- HQ
- Enschede, Netherlands
- Founded
- 2025
- Ownership
- Privately Held (backing)
Morphly doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Morphly shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Morphly in its N-PORT filings yet. We sweep new filings monthly.